Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Panbela Therapeutics Inc (OP: PBLA )

0.3576 +0.0369 (+11.51%)
Streaming Delayed Price Updated: 2:01 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,864
Open 0.3330
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.3207
Today's Range 0.3330 - 0.3576
52wk Range 0.3000 - 0.9500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
From Panbela Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-48.17%
-48.17%
1 Month
+4.10%
+4.10%
3 Month
-0.69%
-0.69%
6 Month
-5.89%
-5.89%
1 Year
-48.17%
-48.17%

More News

Read More
PBLA Stock Earnings: Panbela Therapeutics Beats EPS for Q2 2024
Via InvestorPlace
Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela Announces Oral Presentation at Digestive Disease Week (DDW):
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.